Alqahtani, Q.H.; ALMatrafi, T.A.; Badr, A.M.; Alturaif, S.A.; Mohammed, R.; Siyal, A.; Hasan, I.H.
Sitagliptin Mitigates Diabetic Cardiomyopathy Through Oxidative Stress Reduction and Suppression of VEGF and FLT-1 Expression in Rats. Biomolecules 2025, 15, 1104.
https://doi.org/10.3390/biom15081104
AMA Style
Alqahtani QH, ALMatrafi TA, Badr AM, Alturaif SA, Mohammed R, Siyal A, Hasan IH.
Sitagliptin Mitigates Diabetic Cardiomyopathy Through Oxidative Stress Reduction and Suppression of VEGF and FLT-1 Expression in Rats. Biomolecules. 2025; 15(8):1104.
https://doi.org/10.3390/biom15081104
Chicago/Turabian Style
Alqahtani, Qamraa H., Tahani A. ALMatrafi, Amira M. Badr, Sumayya A. Alturaif, Raeesa Mohammed, Abdulaziz Siyal, and Iman H. Hasan.
2025. "Sitagliptin Mitigates Diabetic Cardiomyopathy Through Oxidative Stress Reduction and Suppression of VEGF and FLT-1 Expression in Rats" Biomolecules 15, no. 8: 1104.
https://doi.org/10.3390/biom15081104
APA Style
Alqahtani, Q. H., ALMatrafi, T. A., Badr, A. M., Alturaif, S. A., Mohammed, R., Siyal, A., & Hasan, I. H.
(2025). Sitagliptin Mitigates Diabetic Cardiomyopathy Through Oxidative Stress Reduction and Suppression of VEGF and FLT-1 Expression in Rats. Biomolecules, 15(8), 1104.
https://doi.org/10.3390/biom15081104
